FDA Approved: SUNOSI — Supplemental Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

FDA approves Axsome Therapeutics' supplemental application for Sunosi (solriamfetol), signaling an updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy
• Obstructive Sleep Apnea

Drugs mentioned

• Sunosi (solriamfetol)

Snippet

SUPPL AP for SUNOSI (SOLRIAMFETOL)